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HIGHLIGHTS 
 Cannabis-related cognitions should affect motivation to seek treatment. 
 We compared treatment-seeking and non-seeking cannabis dependent individuals. 
 Treatment seekers had higher negative expectancies and lower emotional relief self-
efficacy.  
 Treatment seekers had poorer psychosocial functioning and higher self-
perceived cannabis dependence. 
 
 
 
 
ABSTRACT 
Background and Aims: Relatively few cannabis dependent individuals seek treatment and 
little is known about the determinants of treatment seeking. Social Cognitive Theory (SCT) 
provides a useful framework for examining human behaviour and motivation which may be 
helpful in explaining treatment seeking. This study examined the differences in cannabis 
outcome expectancies and cannabis refusal self-efficacy between treatment seekers and non-
treatment seekers with cannabis dependence.  Design: Non-treatment seekers were referred to 
an illicit drug diversion program. Treatment seekers commenced an outpatient cannabis 
treatment program and completed a comprehensive assessment that included measures of 
cannabis outcome expectancies and refusal self-efficacy.  Setting: A public hospital alcohol 
and drug outpatient clinic.  Participants: 269 non-treatment seekers and 195 individuals 
commencing cannabis dependence treatment.  Measurements: The Cannabis Expectancy 
Questionnaire (CEQ), Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ), Severity of 
Dependence Scale – Cannabis (SDS-C), General Health Questionnaire (GHQ-28) and 
Readiness to Change Questionnaire (RTC) were completed. Findings: Treatment seekers had 
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significantly higher levels of negative cannabis outcome expectancies and significantly lower 
levels of emotional relief refusal self-efficacy (belief in ability to resist using cannabis when 
experiencing negative affect) (ps < .001). Treatment seekers had significantly higher levels of 
psychological distress and self-perceived cannabis dependence compared to non-treatment 
seekers (ps < .001).  Conclusions: High negative cannabis outcome expectancies and low 
emotional relief refusal self-efficacy may play a key role in motivation to seek treatment. 
KEYWORDS: cannabis, cannabis dependence, self-efficacy, expectancies, treatment 
initiation, treatment seeking 
 
 
1. INTRODUCTION 
Cannabis is the most widely used illicit drug worldwide, with an estimated 2.8-4.5% of 
the global population using it (Degenhardt and Hall, 2012). Australia is one of the highest 
cannabis-using nations, with 10.7% of Australians using in the past year. Despite many 
individuals meeting the criteria for cannabis dependence, few seek formal treatment (Vendetii 
et al., 2002). A nationally representative study (N= 49,093) found that only 13% of cannabis-
dependent individuals sought formal treatment over the course of their lifetime (Khan et al., 
2013).  In comparison, approximately 13% of alcohol dependent individuals entered treatment 
in a given year (Teesson et al., 2006).  
         In order to better understand why cannabis-dependent individuals present for treatment, 
it is useful to compare the characteristics and attitudes of treatment-seeking and non-treatment 
seeking individuals with cannabis dependence. These studies have found several characteristics 
that differ between these groups. Treatment seekers are more likely to have comorbid mental 
health problems, experience greater impairment as a result of their cannabis use, and encounter 
more problems (e.g., withdrawal symptoms) when attempting to quit cannabis (Agosti and 
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Levin, 2009; Pacek and Vandrey, 2014; van der Pol et al., 2013). They also differ in motivation. 
Those who do not seek formal treatment are more likely to be concerned about the stigma 
associated with seeking treatment, and are more likely to believe that treatment is not required 
in order to reduce their cannabis use (Gates et al., 2012; van der Pol et al., 2013). Vendetti and 
colleagues (2002) found that self-perceived cannabis dependence was a more important 
predictor of treatment initiation than actual level of cannabis-related problems, which were 
similar between treatment seekers and non-seekers. Subjective factors may play a prominent 
role in determining who seeks treatment.  
         Social Cognitive Theory (SCT) provides a useful theoretical framework for 
understanding the initiation, maintenance and treatment of substance use disorders (Bandura, 
1986, 1997, 1999). It highlights the importance of two determinants of behaviour and 
motivation: outcome expectancies and self-efficacy. Cannabis outcome expectancies refer to 
an individual’s beliefs about the positive or negative effects of using cannabis. Individuals with 
low levels of negative expectancies are predicted to have lower levels of perceived cannabis 
dependence and lower motivation to quit or seek formal treatment. On the other hand, 
individuals with high levels of negative expectancies are predicted to experience more 
substantial problems with their cannabis use, have greater perceived cannabis dependence and 
be more motivated to seek formal treatment (Caviness et al., 2013; Connor et al., 2014). High 
levels of positive cannabis expectancies may also be associated with lower likelihood of 
treatment seeking, due to a lack of desire to cease use (Bandura, 1999).   
Cannabis refusal self-efficacy is an individual’s belief in their ability to abstain from 
using cannabis in a variety of situations. In SCT, self-efficacy influences initiation of coping 
behaviors in aversive situations and determines how much effort is exerted to achieve a goal 
(Bandura, 1986, 1997, 1999). Therefore, individuals with high levels of self-efficacy may be 
more confident in their ability to quit cannabis on their own, and hence not see treatment as 
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necessary. SCT also states that self-efficacy for a given behaviour is diminished when repeated 
attempts have failed (Bandura, 1986, 1997, 1999).  
No studies have compared outcome expectancies and self-efficacy in cannabis 
dependent persons who are seeking treatment and those who are not. Given the hypothesized 
importance of motivation for behaviour change, a better understanding of the nature of 
expectancy in treatment seeking could improve outreach efforts. It is hypothesized that 
treatment-seekers will have greater negative cannabis outcome expectancies, lower positive 
expectancies, and lower cannabis refusal-self efficacy than non-treatment seekers. Consistent 
with past research, we predict that treatment seekers will have higher self-perceived cannabis 
dependence (Vendetti et al., 2002), greater readiness to change, and more impaired 
psychological functioning (van der Pol et al., 2013). 
2. METHOD 
2.1 Participants and Procedures 
Data for the treatment-seeking group were obtained from 217 cannabis users who 
voluntarily attended an outpatient alcohol and drug clinic at a large Australian metropolitan 
teaching hospital. Treatment involved one-on-one Cognitive-Behavioral Therapy (CBT), 
comprising five 1-hour sessions delivered over six weeks. The treatment goal was abstinence. 
Treatment was delivered by Masters- or Doctoral-qualified clinical psychologists. 
Questionnaires were administered at the first session. 
Data for the non-treatment seeking group were collected from 680 cannabis users 
referred for assessment as part of the Queensland Illicit Drug Diversion Initiative (QIDDI). 
This program is for individuals charged with cannabis-related offences (e.g., possession) and 
consisted of a two-hour assessment of substance use, psychosocial functioning, and included a 
motivational interviewing component. Participants attend as an alternative to criminal 
prosecution. The current study includes only new cases that have not been previously analyzed 
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(Connor et al., 2014, 2011; Young et al., 2012). Human research ethics approval was obtained. 
Only participants exceeding the Severity of Dependence Scale-Cannabis (Gossop et al., 1995) 
cut-off for dependence were included (see 2.2.3). The final sample comprised 464 participants 
- 269 non-treatment seekers and 195 treatment seekers. Demographic characteristics are 
reported in Table 1. On average, treatment seekers were older than non-treatment seekers (p 
<.001) and less likely to have completed high school (p<.001). Similar differences have been 
observed in other studies (Agosti and Levin, 2009; Pacek and Vandrey, 2014). The mean 
Alcohol Use Disorders Identification Test score for non-treatment seekers was 8.32 (SD = 
6.75), with 17% exceeding the cut-off for likely alcohol dependence (men = 15+, women = 
13+; Babor et al., 2001). Treatment seekers had a mean score of 3.41 (SD = 7.70), with 10% 
exceeding the cut-off. 
2.2 Measures 
2.2.1 Cannabis Expectancy Questionnaire (CEQ; Connor et al., 2011). The 45-item CEQ was 
assessed positive and negative cannabis outcome expectancies. The two subscales have 
excellent internal consistency (≥ 0.90) and the CEQ’s two-factor structure and criterion 
validity have been confirmed in clinical samples (Connor et al., 2011). 
 2.2.2 Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ; Young et al., 2012). The 14-
item CRSEQ assessed cannabis refusal self-efficacy. It comprises three subscales: Emotional 
Relief (six items, e.g., ‘When I feel sad’), Opportunistic (five items, e.g., ‘When someone 
offers me a smoke’) and Social Facilitation (three items, e.g., ‘When I want to feel more 
accepted by friends’). Internal consistency of the CRSEQ is good-to-excellent (=0.84-0.97) 
and the three-factor structure and criterion validity has been established in clinical samples 
(Young et al., 2012). 
2.2.3 Severity of Dependence Scale – Cannabis (SDS-C; Gossop et al., 1995). The SDS-C is a 
five-item questionnaire that assesses the degree of cannabis dependence. It is sensitive to 
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severity of cannabis dependence (Swift et al., 2000). The cannabis dependence cut-off is 3 
(possible range: 0 to 15; Swift et al., 1998).  
2.2.4 Readiness to Change Questionnaire (RTC; Heather and Rollnick, 1993). The 12-item 
RTC assessed motivation to reduce cannabis use. Individuals were classified as pre-
contemplation, contemplation or action stage. The internal consistency of the RTC is good (= 
0.73 – 0.85) and concurrent and predictive validity has been established (Heather and Rollnick, 
1993). 
2.2.5 General Health Questionnaire – 28 (GHQ-28; Goldberg and Williams, 1998). The 28-
item version of the GHQ was used to assess recent changes in psychological functioning. It 
comprises four sub-scales: Somatic Symptoms, Anxiety, Social Dysfunction and Depression. 
The GHQ is a widely used measure of psychological health and has strong psychometric 
properties (Goldberg et al., 1997; Wernecke et al., 2000).  
3. RESULTS 
Forty-two participants had missing data >50% of variables, and were excluded from 
the analyses, leaving 464 cases. There was 3.17% missing data in the sample analyzed, 
determined to be Missing Completely at Random (MCAR) by Little’s (1988) MCAR test, 2= 
240.69 (433), p > .99. Multiple Imputation (5 imputations) was employed, an optimal approach 
to handling missing data (Graham, 2009).  
Independent samples t-tests (α= .01) were conducted to examine the differences 
between treatment seekers and non-treatment seekers – see Table 2. Treatment seekers had 
significantly higher levels of cannabis dependence severity, negative expectancies, somatic 
symptoms, anxiety, social dysfunction and depression than non-treatment seekers (ps < .001). 
Treatment seekers had significantly lower levels of emotional relief self-efficacy than non-
treatment seekers (p< .001). All differences were of a medium-to-large effect size, except social 
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dysfunction. There was no significant difference between groups on positive expectancies, 
opportunistic or social facilitation refusal self-efficacy.  
There was a significant association between stage of change and treatment seeking, 
2(2) = 29.85, p <.001. The association was moderate, Cramer’s V = 0.26, p <.001. The odds 
of being in the action stage of change were 1.74 times higher for a treatment seeker (64.8%) 
than a non-treatment seeker (51.5%). Interestingly, there was little difference in the proportion 
of treatment seekers (35.2%) and non-treatment seekers (33.5%) in the contemplation stage of 
change (OR = 1.08). Not surprisingly, no treatment seekers were in the pre-contemplation 
stage.  
A logistic regression revealed that in addition to age and education, only the SCT 
variables of emotional relief self-efficacy and negative expectancies were significantly 
associated with treatment seeking status (ps <.001). The addition of these predictors 
significantly improved fit over a model that included age and education, and improved 
classification accuracy from 63.0% to 76.2%, 2(5) = 136.88, p<.001, Nagelkerke-R2 = 0.41).  
4. DISCUSSION  
         This study is the first to compare cannabis outcome expectancies and refusal self-
efficacy in treatment seeking and non–treatment seeking individuals with cannabis 
dependence.  As predicted, treatment seekers had higher levels of negative expectancies, and 
this effect size was large. This suggests that negative expectancies play a more substantial role 
in motivating individuals to change their behaviour and seek help. Past research has suggested 
negative expectancies play a protective role, and are associated with non-use of cannabis 
among adults (Schafer and Brown, 1991) and adolescents (Alfonso and Dunn, 2007). Higher 
negative expectancies have also been observed among those who have quit cannabis (Aarons 
et al., 2001) and are associated with lower odds of relapse during self-initiated cessation (Boden 
et al., 2013). Our results suggest that treatment entry may be increased by encouraging 
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dependent individuals to reflect on the negative impact of cannabis use, perhaps through 
highlighting the discrepancy between continued use and other life goals (Miller and Rollnick, 
2012). The hypothesis that non-treatment seekers would hold higher positive expectancies was 
not supported; these expectancies may play a greater role in cannabis initiation and escalation 
of use (Alfonso and Dunn, 2007; Schafer and Brown, 1991).   
We predicted that cannabis refusal self-efficacy would be lower among treatment 
seekers. This was the case for emotional relief refusal self-efficacy but there were no 
differences for opportunistic or social facilitation self-efficacy. Since treatment seekers in our 
study also experienced greater levels of psychological distress, these findings suggest they are 
using cannabis to cope (Benschop et al., 2015; Copeland et al., 2001; Moitra et al., 2015).  Lack 
of self-efficacy to resist cannabis when experiencing distress may motivate individuals to seek 
help because they believe they are unable to make effective changes on their own. Past research 
has shown that treatment seekers are likely to have had more prior quit attempts than non-
treatment seekers (van der Pol et al., 2013). Treatment seekers’ self-efficacy may therefore 
have been reduced as a result of failed past attempts (Bandura, 1997). This requires 
investigation in future research.  
Treatment seekers reported greater severity of cannabis dependence than non-treatment 
seekers, despite both groups reporting a significant degree of cannabis-related problems and 
concern. This was the largest effect size for all variables examined. This result is consistent 
with past research that self-perceived cannabis dependence is the most important predictor of 
treatment initiation (Vendetii et al., 2002). Although the non-treatment seeking group did not 
seek formal help for their cannabis dependence, half of this group was already making self-
initiated changes to their cannabis use. Treatment-seekers reported higher motivation to reduce 
their cannabis use and were more likely to be actively making changes to their behaviour. It 
may be that non-treatment seekers are at an earlier stage of problematic use or have less co-
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occurring psychological distress because of a greater repertoire of alternative coping strategies. 
A future longitudinal study could provide a clearer understanding of the path to seeking formal 
treatment. Tracking outcome expectancies, self-efficacy and severity of dependence over time, 
especially during self-initiated cessation, could determine whether changes in these variables 
does in fact precede the decision to enter formal treatment. If confirmed, such findings could 
inform assessment and feedback-based programs, such as the Marijuana Check-Up (Stephens 
et al., 2007), to facilitate discussion around seeking treatment.   
Another limitation of our study was that the non-treatment seeking sample comprised 
individuals who had been prosecuted by the police as a result of their cannabis use. This may 
limit generalizability to dependent users who have not experienced legal consequences from 
use, but has the benefit of being unaffected by self-selection sampling bias. 
In conclusion, our findings suggest that formal treatment for cannabis dependence may 
be sought when individuals experience significant psychosocial impairment as a result of their 
cannabis use, hold high negative cannabis outcome expectancies and lack confidence in their 
ability to regulate negative affect without using cannabis. 
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Table 1. Sample Characteristics  
  Non- 
Treatment 
Seekers 
(n = 269) 
Treatment Seekers 
(n = 195) 
p-value 
Age (M, in years) 26.19 30.03 <.001 
Gender (%) 
     Male 
     Female 
  
205 (76%) 
64   (24%) 
  
144 (74%) 
51   (26%) 
 
 
.587 
Completed High School (%) 
      Yes 
       No 
  
185 (70%) 
82   (30%) 
  
94 (51%) 
92 (49%) 
 
 
<.001 
Currently Unemployed (%) 
      Yes 
      No 
  
55   (20%) 
214 (80%) 
  
40   (21%) 
155 (79%) 
 
 
.986 
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Table 2. Results from Independent Sample t-tests between Treatment Seekers and Non-
Treatment Seekers with Cannabis Dependence 
  Non- 
Treatment 
Seekers 
M (SD) 
  
Treatment 
Seekers 
M (SD) 
  
  
t 
  
  
p 
  
  
Cohen’s d 
SDS Total 5.20 (2.42) 9.57 (2.84) 18.02 <.001 1.66 
CEQ: Positive 
Expectancy 
52.45 
(13.12) 
52.24 
(12.20) 
0.19 .851 0.02 
CEQ: 
Negative 
Expectancy 
61.92 
(17.34) 
81.10 
(19.88) 
11.04 <.001 1.03 
CRSEQ: 
Emotional 
Relief 
23.95 (8.80) 19.55 (8.90) 5.40 <.001 0.50 
CRSEQ: 
Opportunistic 
17.72 (7.11) 17.24 (8.74) 0.64 .522 0.06 
CRSEQ: 
Social 
Facilitation 
14.14 (3.94) 13.86 (4.08) 0.78 .433 0.07 
GHQ: Somatic 
Symptoms 
5.28 (3.87) 7.32 (4.53) 5.23 <.001 0.48 
GHQ: Anxiety 5.35 (4.77) 9.55 (5.64) 8.59 <.001 0.80 
GHQ: Social 
Dysfunction 
6.78 (3.19) 8.33 (4.67) 4.09 <.001 0.39 
GHQ: 
Depression 
3.08 (3.94) 6.65 (6.07) 7.40 <.001 0.70 
Note. SDS= Severity of Dependence; CEQ = Cannabis Expectancy Questionnaire; CRSEQ = 
Cannabis Refusal Self-Efficacy Questionnaire; GHQ = General Health Questionnaire.  
 
 
